Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06627959

StatSeal vs Figure-of-Eight Suture for Vascular Closure in AF Ablation

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
160 (actual)
Sponsor
Mid and South Essex NHS Foundation Trust · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study, titled aims to compare two vascular closure techniques after catheter ablation for atrial fibrillation (AF). Catheter ablation is a common procedure used to treat AF, but after the procedure, It is important to close the access site in the blood vessel to prevent bleeding. This study will evaluate whether the StatSeal device, a haemostatic disc, can help patients recover more quickly compared to the traditional figure-of-eight suture technique. The primary objective of the study is to determine whether StatSeal reduces the time it takes for patients to start walking after the procedure (known as Time to Ambulation). Secondary objectives include comparing the time to complete haemostasis, discharge eligibility, incidence of adverse events, and patient comfort between the two techniques. Participants in the study will be randomly assigned to receive either the StatSeal device or the figure-of-eight suture after their AF ablation procedure. The study will recruit 160 participants across multiple hospital sites, with 80 participants in each group. Both techniques are standard methods, and participants will be closely monitored for safety throughout the study. By comparing these two closure techniques, the study aims to improve the recovery process for patients undergoing AF ablation and provide evidence on which method leads to better outcomes and patient experiences.

Conditions

Interventions

TypeNameDescription
DEVICEStatsealThis is a vascular closure device which works independently of the clotting cascade to seal access sites
DEVICEFigure of eight sutureThe figure of eight suture is commonly used for vascular access closure

Timeline

Start date
2025-01-03
Primary completion
2025-12-12
Completion
2026-01-01
First posted
2024-10-04
Last updated
2025-12-23

Locations

3 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT06627959. Inclusion in this directory is not an endorsement.